{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:19:48Z","timestamp":1788542388132,"version":"build-2803163510"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2025GXNSFAA069977"],"award-info":[{"award-number":["2025GXNSFAA069977"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["24KJB180015"],"award-info":[{"award-number":["24KJB180015"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118371","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:18:28Z","timestamp":1787152708000},"page":"118371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["The regulatory role of non-coding RNAs in taxane resistance of breast cancer"],"prefix":"10.1016","volume":"254","author":[{"given":"Cuicui","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinzheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faheem Ahmed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuruliarizki Shinta","family":"Pandupuspitasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7784-6325","authenticated-orcid":false,"given":"Chunjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2026.118371_b0005","first-page":"171","article-title":"Breast cancer treatment","volume":"104","author":"Trayes","year":"2021","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bcp.2026.118371_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.12.005","article-title":"Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis","volume":"318","author":"Zhao","year":"2020","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0015","first-page":"40","article-title":"Non-metastatic breast cancer: clinical presentation and patterns of surgical treatment","volume":"5","author":"Abdulhadi","year":"2009","journal-title":"Al-Kindy College Med. J."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/10717544.2022.2154411","article-title":"Effect and mechanism of paclitaxel loaded on magnetic Fe3O4@ mSiO2-NH2-FA nanocomposites to MCF-7 cells","volume":"30","author":"Ni","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bcp.2026.118371_b0025","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84791","article-title":"Structural insight into the stabilization of microtubules by taxanes","volume":"12","author":"Prota","year":"2023","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.bcp.2026.118371_b0030","first-page":"890","article-title":"Research progress on the source, production, and anti-cancer mechanisms of paclitaxel","volume":"18","author":"Yan-Hua","year":"2020","journal-title":"Chin. J. Nat. Med."},{"issue":"15","key":"10.1016\/j.bcp.2026.118371_b0035","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/s41388-017-0115-x","article-title":"Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer","volume":"37","author":"Ireland","year":"2018","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0040","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bbrc.2016.08.127","article-title":"Role of paclitaxel on critical nucleation concentration of tubulin and its effects thereof","volume":"478","author":"Verma","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2026.118371_b0045","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10495-017-1375-1","article-title":"Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)","volume":"22","author":"Rathore","year":"2017","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0050","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14453","article-title":"VIRMA promotes neuron apoptosis via inducing m6A methylation of STK10 in spinal cord injury animal models","volume":"30","author":"Hong","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"24","key":"10.1016\/j.bcp.2026.118371_b0055","doi-asserted-by":"crossref","first-page":"17163","DOI":"10.1074\/jbc.M114.558288","article-title":"Role of autophagy in cisplatin resistance in ovarian cancer cells","volume":"289","author":"Wang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118371_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100915","article-title":"Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy","volume":"67","author":"Yu","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"23","key":"10.1016\/j.bcp.2026.118371_b0065","doi-asserted-by":"crossref","first-page":"783","DOI":"10.21037\/atm.2019.11.39","article-title":"eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancer","volume":"7","author":"Wang","year":"2019","journal-title":"Ann. Translat. Med."},{"key":"10.1016\/j.bcp.2026.118371_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116295","article-title":"Angelica sinensis polysaccharide suppresses the Wnt\/\u03b2-catenin-mediated malignant biological behaviors of breast cancer cells via the miR-3187-3p\/PCDH10 axis","volume":"225","author":"Cai","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118371_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116120","article-title":"H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis","volume":"222","author":"Zhao","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118371_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155944","article-title":"Enhancement of gemcitabine sensitivity in intrahepatic cholangiocarcinoma through Saikosaponin-a mediated modulation of the p-AKT\/BCL-6\/ABCA1 axis","volume":"133","author":"Song","year":"2024","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.bcp.2026.118371_b0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3892\/ol.2021.13168","article-title":"Paclitaxel resistance is mediated by NF-\u03baB on mesenchymal primary breast cancer cells","volume":"23","author":"Esparza-Lopez","year":"2022","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.03.041","article-title":"Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-025-01722-1","article-title":"Application of single-cell and spatial omics in deciphering cellular hallmarks of cancer drug response and resistance","volume":"18","author":"Cheng","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0100","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev-biochem-040320-103615","article-title":"The Wnt pathway: from signaling mechanisms to synthetic modulators","volume":"91","author":"Rim","year":"2022","journal-title":"Annu. Rev. Biochem"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13046-019-1231-y","article-title":"Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing \u03b2-catenin","volume":"38","author":"Shen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118371_b0110","first-page":"4529","article-title":"Research progress on the PI3K\/AKT signaling pathway in gynecological cancer","volume":"19","author":"Shi","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.bcp.2026.118371_b0115","doi-asserted-by":"crossref","DOI":"10.17219\/acem\/127681","article-title":"Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K\/AKT signaling pathway","volume":"29","author":"Li","year":"2020","journal-title":"Adv. Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/wrna.1213","article-title":"miRNA sponges: soaking up miRNAs for regulation of gene expression","volume":"5","author":"Bak","year":"2014","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"issue":"suppl 2","key":"10.1016\/j.bcp.2026.118371_b0125","doi-asserted-by":"crossref","first-page":"ii57","DOI":"10.1136\/ard.2004.028266","article-title":"Nuclear factor (NF)-\u03baB proteins: therapeutic targets","volume":"63","author":"Verma","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"42","key":"10.1016\/j.bcp.2026.118371_b0130","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1038\/sj.onc.1205848","article-title":"The function of multiple I\u03baB: NF-\u03baB complexes in the resistance of cancer cells to Taxol-induced apoptosis","volume":"21","author":"Dong","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","article-title":"Cyclin-dependent protein kinases and cell cycle regulation in biology and disease","volume":"10","author":"Pellarin","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0140","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/bcr2231","article-title":"Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells","volume":"11","author":"Nakayama","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bcp.2026.118371_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154933","article-title":"Quercetin induces MGMT+ glioblastoma cells apoptosis via dual inhibition of Wnt3a\/\u03b2-Catenin and Akt\/NF-\u03baB signaling pathways","volume":"118","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0150","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s13277-013-0794-z","article-title":"Metadherin confers chemoresistance of cervical cancer cells by inducing autophagy and activating ERK\/NF-\u03baB pathway","volume":"34","author":"Zhang","year":"2013","journal-title":"Tumor Biol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118371_b0155","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bcp.2026.118371_b0160","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14728222.2023.2225767","article-title":"Modulating multidrug resistance to drug-based antitumor therapies through NF-\u03baB signaling pathway: mechanisms and perspectives","volume":"27","author":"Wu","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","article-title":"ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer","volume":"41","author":"Dong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0170","first-page":"984","article-title":"Targeting of PI3K\/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance","volume":"4","author":"Estruch","year":"2021","journal-title":"Cancer Drug Resistance."},{"key":"10.1016\/j.bcp.2026.118371_b0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fonc.2020.00046","article-title":"Caveolin-1 promotes chemoresistance of gastric cancer cells to cisplatin by activating WNT\/\u03b2-catenin pathway","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s43556-026-00475-8","article-title":"TELO2-interacting protein 1 (TTI1), a novel Wnt\/\u03b2-catenin target gene, decreases chemo-sensitivity in colorectal cancer by modulating DNA damage responses","volume":"7","author":"Chen","year":"2026","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bcp.2026.118371_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.659297","article-title":"Autophagy blockade by Ai Du Qing formula promotes chemosensitivity of breast cancer stem cells via GRP78\/\u03b2-catenin\/ABCG2 axis","volume":"12","author":"Liao","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0195","doi-asserted-by":"crossref","first-page":"410","DOI":"10.21037\/atm-21-698","article-title":"PIK3CA mutation confers resistance to chemotherapy in triple-negative breast cancer by inhibiting apoptosis and activating the PI3K\/AKT\/mTOR signaling pathway","volume":"9","author":"Hu","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"11","key":"10.1016\/j.bcp.2026.118371_b0200","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1111\/jcmm.13800","article-title":"Heme oxygenase\u20101 induction mediates chemoresistance of breast cancer cells to pharmorubicin by promoting autophagy via PI 3K\/Akt pathway","volume":"22","author":"Pei","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"8","key":"10.1016\/j.bcp.2026.118371_b0205","first-page":"5134","article-title":"PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K\/AKT\/mTOR pathway","volume":"11","author":"Zhang","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0210","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118371_b0215","article-title":"Sustained activation of non-canonical NF-\u03baB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL","author":"Lim","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118371_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116406","article-title":"Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance","volume":"226","author":"Wu","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118371_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112063","article-title":"An extensive overview of the role of lncRNAs generated from immune cells in the etiology of cancer","volume":"133","author":"Luo","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118371_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104161","article-title":"P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators","volume":"29","author":"Guo","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"5858","key":"10.1016\/j.bcp.2026.118371_b0240","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1126\/science.1152623","article-title":"The two faces of miRNA","volume":"318","author":"Buchan","year":"2007","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0245","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1038\/ncomms4979","article-title":"Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes","volume":"5","author":"Ilott","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118371_b0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2017.01.025","article-title":"Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer","volume":"466","author":"Chen","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"5543","key":"10.1016\/j.bcp.2026.118371_b0255","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","article-title":"Identification of novel genes coding for small expressed RNAs","volume":"294","author":"Lagos-Quintana","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118371_b0260","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.omto.2021.11.005","article-title":"Long non-coding RNAs: biogenesis, functions, and clinical significance in gastric cancer","volume":"23","author":"Liu","year":"2021","journal-title":"Molecular Therapy-Oncolytics."},{"issue":"11","key":"10.1016\/j.bcp.2026.118371_b0265","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0270","first-page":"239","article-title":"LncRNA MALAT1 potentiates autophagy\u2013associated cisplatin resistance by regulating the microRNA\u201330b\/autophagy\u2013related gene 5 axis in gastric cancer","volume":"54","author":"Xi","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118371_b0275","first-page":"3821","article-title":"Downregulation of miR\u2013200c\u20133p contributes to the resistance of breast cancer cells to paclitaxel by targeting SOX2","volume":"40","author":"Chen","year":"2018","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2026.118371_b0280","doi-asserted-by":"crossref","first-page":"e3071","DOI":"10.1038\/cddis.2017.460","article-title":"Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0285","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1515\/med-2019-0049","article-title":"miR-107 enhances the sensitivity of breast cancer cells to paclitaxel","volume":"14","author":"Ma","year":"2019","journal-title":"Open Medicine."},{"issue":"17","key":"10.1016\/j.bcp.2026.118371_b0290","doi-asserted-by":"crossref","first-page":"23668","DOI":"10.18632\/oncotarget.8056","article-title":"MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.118371_b0295","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.2147\/OTT.S241640","article-title":"MiR-153-5p enhances the sensitivity of triple-negative breast cancer cells to paclitaxel by inducing G2M phase arrest","author":"Wang","year":"2020","journal-title":"OncoTargets Therapy"},{"issue":"8","key":"10.1016\/j.bcp.2026.118371_b0300","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41419-020-02855-6","article-title":"MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1","volume":"11","author":"Bao","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bcp.2026.118371_b0305","first-page":"361","article-title":"Evaluation of miR-34a effect on CCND1 mRNA level and sensitization of breast cancer cell lines to paclitaxel","volume":"24","author":"Irani","year":"2020","journal-title":"Iran. Biomed. J."},{"issue":"24","key":"10.1016\/j.bcp.2026.118371_b0310","doi-asserted-by":"crossref","first-page":"20070","DOI":"10.18632\/oncotarget.4039","article-title":"MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.118371_b0315","doi-asserted-by":"crossref","first-page":"11097","DOI":"10.2147\/OTT.S213780","article-title":"miR-7 reverses breast cancer resistance to chemotherapy by targeting MRP1 and BCL2","author":"Hong","year":"2019","journal-title":"OncoTargets Therapy"},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0320","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.3892\/ol.2016.5139","article-title":"Overexpression of microRNA\u201324 increases the sensitivity to paclitaxel in drug\u2013resistant breast carcinoma cell lines via targeting ABCB9","volume":"12","author":"Gong","year":"2016","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0325","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.18632\/oncotarget.6790","article-title":"Micro RNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR","volume":"7","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.118371_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110566","article-title":"miR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway","volume":"103","author":"Shi","year":"2023","journal-title":"Cell. Signal."},{"issue":"28","key":"10.1016\/j.bcp.2026.118371_b0335","doi-asserted-by":"crossref","first-page":"21496","DOI":"10.1074\/jbc.M109.083337","article-title":"MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression","volume":"285","author":"Zhou","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0340","doi-asserted-by":"crossref","DOI":"10.4149\/neo_2018_181207N930","article-title":"MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4","volume":"66","author":"Tao","year":"2019","journal-title":"Neoplasma"},{"key":"10.1016\/j.bcp.2026.118371_b0345","doi-asserted-by":"crossref","unstructured":"H-d Zhang, Sun D-w, Mao L, Zhang J, Jiang L-h, Li J, et al. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel. Biochem. Biophys. Res. Commun.. 2015;465(4):702-13.","DOI":"10.1016\/j.bbrc.2015.08.053"},{"issue":"7","key":"10.1016\/j.bcp.2026.118371_b0350","first-page":"888","article-title":"MiR-433 reverses chemoresistance to docetaxel by targeting Notch1 in breast cancer cells","volume":"38","author":"Xiaolei","year":"2018","journal-title":"J. Southern Med. Univ."},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0355","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbrc.2016.09.087","article-title":"Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling","volume":"479","author":"Xu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0360","first-page":"7855","article-title":"ATP citrate lyase expression is associated with advanced stage and prognosis in gastric adenocarcinoma","volume":"8","author":"Qian","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0365","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/cancers15030562","article-title":"Enhanced de novo lipid synthesis mediated by FASN induces chemoresistance in colorectal cancer","volume":"15","author":"Han","year":"2023","journal-title":"Cancers"},{"issue":"29","key":"10.1016\/j.bcp.2026.118371_b0370","doi-asserted-by":"crossref","first-page":"27436","DOI":"10.1074\/jbc.M413330200","article-title":"StarD10, a START domain protein overexpressed in breast cancer, functions as a phospholipid transfer protein","volume":"280","author":"Olayioye","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2026.118371_b0375","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbrc.2017.04.045","article-title":"Potentiation of docetaxel sensitivity by miR-638 via regulation of STARD10 pathway in human breast cancer cells","volume":"487","author":"Zhao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"47","key":"10.1016\/j.bcp.2026.118371_b0380","doi-asserted-by":"crossref","first-page":"82123","DOI":"10.18632\/oncotarget.18899","article-title":"Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation","volume":"8","author":"Tracz-Gaszewska","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0385","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3724\/abbs.2021006","article-title":"miR-1205\/DNAJB1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53\/TAp63 signaling: miR-1205\/DNAJB1 reverses docetaxel chemoresistance in TNBC","volume":"54","author":"Yin","year":"2021","journal-title":"Acta Biochim. Biophy. Sin."},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0390","doi-asserted-by":"crossref","first-page":"11310","DOI":"10.1080\/21655979.2022.2068756","article-title":"Overexpression of microRNA-145 enhanced docetaxel sensitivity in breast cancer cells via inactivation of protein kinase B gamma-mediated phosphoinositide 3-kinase-protein kinase B pathway","volume":"13","author":"Zhou","year":"2022","journal-title":"Bioengineered."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0395","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10495-013-0904-9","article-title":"Superoxide activates mTOR\u2013eIF4E\u2013Bax route to induce enhanced apoptosis in leukemic cells","volume":"19","author":"Chaudhuri","year":"2014","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0400","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3892\/or.2015.3866","article-title":"miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression","volume":"33","author":"Yao","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2026.118371_b0405","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.gene.2016.11.037","article-title":"MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel","volume":"600","author":"Yang","year":"2017","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.bcp.2026.118371_b0410","doi-asserted-by":"crossref","first-page":"E1570","DOI":"10.1073\/pnas.1719577115","article-title":"Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer","volume":"115","author":"Thu","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2026.118371_b0415","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1007\/s13277-014-1834-z","article-title":"MicroRNA-452 contributes to the docetaxel resistance of breast cancer cells","volume":"35","author":"Hu","year":"2014","journal-title":"Tumor Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0420","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1534-5807(02)00258-7","article-title":"CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells","volume":"3","author":"Chen","year":"2002","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0425","doi-asserted-by":"crossref","first-page":"15424","DOI":"10.1038\/srep15424","article-title":"MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bcp.2026.118371_b0430","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1158\/1541-7786.MCR-17-0205","article-title":"Chemoradiotherapy resistance in colorectal cancer cells is mediated by Wnt\/\u03b2-catenin signaling","volume":"15","author":"Emons","year":"2017","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0435","article-title":"MicroRNA-3646 contributes to docetaxel resistance in human breast cancer cells by GSK-3\u03b2\/\u03b2-catenin signaling pathway","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bcp.2026.118371_b0440","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10549-011-1424-3","article-title":"miRNA-34a is associated with docetaxel resistance in human breast cancer cells","volume":"131","author":"Kastl","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0445","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/nar\/gkad1142","article-title":"The miRNA\u2013target interactions: an underestimated intricacy","volume":"52","author":"Diener","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2026.118371_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112873","article-title":"CircGNAO1 suppresses hepatocellular carcinoma progression and metastasis via sponging miR-182-5p and regulating FOXO1 expression","volume":"140","author":"Ju","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0455","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1752-0509-8-83","article-title":"Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer","volume":"8","author":"Paci","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.bcp.2026.118371_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106979","article-title":"CircIQGAP1 regulates RCAN1 and RCAN2 through the mechanism of ceRNA and promotes the growth of malignant glioma","volume":"197","author":"Huang","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0465","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molcel.2014.09.018","article-title":"Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition","volume":"56","author":"Bosson","year":"2014","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0470","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12864-017-3790-7","article-title":"High-throughput validation of ceRNA regulatory networks","volume":"18","author":"Chiu","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bcp.2026.118371_b0475","doi-asserted-by":"crossref","unstructured":"C. Gao, Li H, Zhuang J, Zhang H, Wang K, Yang J, et al. The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas. Cancer Manage. Res. 2018:1-11.","DOI":"10.2147\/CMAR.S182521"},{"key":"10.1016\/j.bcp.2026.118371_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147230","article-title":"Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b","volume":"860","author":"Wei","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2026.118371_b0485","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.lfs.2019.04.063","article-title":"LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c\/CDK6 axis","volume":"228","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.118371_b0490","article-title":"Long non-coding RNA UCA1 modulates paclitaxel resistance in breast cancer via miR-613\/CDK12 axis","volume":"2777\u201388","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0495","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00418-019-01794-4","article-title":"Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p\/CDK19","volume":"152","author":"Zheng","year":"2019","journal-title":"Histochem. Cell Biol."},{"issue":"21","key":"10.1016\/j.bcp.2026.118371_b0500","doi-asserted-by":"crossref","first-page":"24171","DOI":"10.18632\/aging.203672","article-title":"LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p\/MTDH pathway-mediated autophagy and genomic instability","volume":"13","author":"Li","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.bcp.2026.118371_b0505","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/1440-1681.13758","article-title":"LncRNA PRKCQ\u2010AS1 regulates paclitaxel resistance in triple\u2010negative breast cancer cells through miR\u2010361\u20105p\/PIK3C3 mediated autophagy","volume":"50","author":"Zheng","year":"2023","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118371_b0510","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1111\/jcmm.13679","article-title":"Long non\u2010coding RNA FTH 1P3 activates paclitaxel resistance in breast cancer through miR\u2010206\/ABCB 1","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0515","first-page":"698","article-title":"Long-chain non-coding RNA MALAT1 regulates paclitaxel resistance of breast cancer cells by targeting miR-485-3p","volume":"40","author":"Aini","year":"2020","journal-title":"J. Southern Med. Univ."},{"issue":"23","key":"10.1016\/j.bcp.2026.118371_b0520","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1080\/15384101.2020.1839700","article-title":"Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513\/PBLD axis in breast cancer cells","volume":"19","author":"Zhu","year":"2020","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0525","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s13577-021-00541-z","article-title":"Long non-coding RNA TPT1-AS1 sensitizes breast cancer cell to paclitaxel and inhibits cell proliferation by miR-3156-5p\/caspase 2 axis","volume":"34","author":"Huang","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.bcp.2026.118371_b0530","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2147\/CMAR.S238513","article-title":"Circ-ABCB10 contributes to paclitaxel resistance in breast cancer through Let-7a-5p\/DUSP7 axis","author":"Yang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bcp.2026.118371_b0535","doi-asserted-by":"crossref","first-page":"9497","DOI":"10.2147\/OTT.S252886","article-title":"Circ_0006528 contributes to paclitaxel resistance of breast cancer cells by regulating miR-1299\/CDK8 axis","author":"Liu","year":"2020","journal-title":"OncoTargets and therapy."},{"issue":"7","key":"10.1016\/j.bcp.2026.118371_b0540","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/1759-7714.13475","article-title":"Circ\u2010RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR\u2010140\u20105p","volume":"11","author":"Zang","year":"2020","journal-title":"Thoracic Cancer."},{"issue":"19","key":"10.1016\/j.bcp.2026.118371_b0545","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/1759-7714.14928","article-title":"Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR\u2010136\u20105p\/YWHAZ axis","volume":"14","author":"Kong","year":"2023","journal-title":"Thoracic Cancer."},{"key":"10.1016\/j.bcp.2026.118371_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116708","article-title":"Natural products as glycolytic inhibitors for cervical cancer treatment: a comprehensive review","volume":"175","author":"Liu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118371_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176601","article-title":"Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma","volume":"974","author":"Zhao","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118371_b0560","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.2147\/CMAR.S307595","article-title":"Silencing of circHIPK3 sensitizes paclitaxel-resistant breast cancer cells to chemotherapy by regulating HK2 through targeting miR-1286","author":"Ni","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"8","key":"10.1016\/j.bcp.2026.118371_b0565","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1158\/1535-7163.MCT-12-1019","article-title":"TLR4 is a novel determinant of the response to paclitaxel in breast cancer","volume":"12","author":"Rajput","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0570","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jb\/mvaa148","article-title":"circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p\/TLR4 pathway","volume":"169","author":"Zheng","year":"2021","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0575","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-021-01332-8","article-title":"CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K\/AKT pathway","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0580","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/mc.23498","article-title":"CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple\u2010negative breast cancer by targeting miR\u2010761\/DACT2 signaling axis","volume":"62","author":"Huang","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2026.118371_b0585","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.2147\/OTT.S247776","article-title":"LINC00461 overexpression can induce docetaxel resistance in breast cancer by interacting with miR-411-5p","author":"Zhang","year":"2020","journal-title":"OncoTargets Therapy"},{"key":"10.1016\/j.bcp.2026.118371_b0590","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nbd.2014.06.006","article-title":"Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT\/GSK-3\u03b2 signaling","volume":"70","author":"Fuchs","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2026.118371_b0595","doi-asserted-by":"crossref","DOI":"10.1177\/03946320221105608","article-title":"LINC00680 modulates docetaxel resistance in breast cancer via the miR-320b\/CDKL5 axis","volume":"36","author":"Li","year":"2022","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118371_b0600","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/kjm2.12728","article-title":"FTO\u2010mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR\u20101343\u20103p","volume":"39","author":"Lin","year":"2023","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0605","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11010-023-04908-8","article-title":"LncRNA MCM3AP-AS1 promotes chemoresistance in triple-negative breast cancer through the miR-524-5p\/RBM39 axis","volume":"480","author":"Wang","year":"2025","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0610","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1620\/tjem.2023.J039","article-title":"Circrna circabcb1 diminishes the sensitivity of breast cancer cells to docetaxel by sponging mir-153-3p","volume":"261","author":"Liu","year":"2023","journal-title":"Tohoku J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0615","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13058-018-0944-8","article-title":"The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells","volume":"20","author":"Kim","year":"2018","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0620","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1038\/s41467-022-31764-9","article-title":"Hypoxia induces HIF1\u03b1-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy","volume":"13","author":"Ma","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118371_b0625","doi-asserted-by":"crossref","unstructured":"G.L. Wang, Jiang B-h, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. 1995;92(12):5510-4.","DOI":"10.1073\/pnas.92.12.5510"},{"issue":"24","key":"10.1016\/j.bcp.2026.118371_b0630","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.3390\/cancers14246054","article-title":"Hypoxia-inducible factor-1: a novel therapeutic target for the management of cancer, drug resistance, and cancer-related pain","volume":"14","author":"Bui","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.118371_b0635","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2147\/CMAR.S166136","article-title":"The effect of HIF-1\u03b1 and PKM1 expression on acquisition of chemoresistance","author":"Okazaki","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bcp.2026.118371_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100821","article-title":"Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1\u03b1\/miR-494\/Survivin signaling pathway","volume":"32","author":"Li","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.bcp.2026.118371_b0645","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biocel.2016.01.006","article-title":"Cross-talk between EPAS-1\/HIF-2\u03b1 and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell","volume":"72","author":"Zhao","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"19","key":"10.1016\/j.bcp.2026.118371_b0650","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.7150\/jca.46898","article-title":"EPAS1 targeting by miR-152-3p in paclitaxel-resistant breast cancer","volume":"11","author":"Song","year":"2020","journal-title":"J. Cancer"},{"issue":"11","key":"10.1016\/j.bcp.2026.118371_b0655","doi-asserted-by":"crossref","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","article-title":"Exosomes\u2500 nature's lipid nanoparticles, a rising star in drug delivery and diagnostics","volume":"16","author":"Tenchov","year":"2022","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0660","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","article-title":"Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2026.118371_b0665","doi-asserted-by":"crossref","first-page":"36405","DOI":"10.31083\/FBL36405","article-title":"Extracellular vesicles: recent advances and perspectives","volume":"30","author":"Ragni","year":"2025","journal-title":"Front. Biosci.-Landmark"},{"key":"10.1016\/j.bcp.2026.118371_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123468","article-title":"Intercellular communication via exosomes: a new paradigm in the pathophysiology of neurodegenerative disorders","volume":"365","author":"Satao","year":"2025","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.bcp.2026.118371_b0675","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1021\/acs.molpharmaceut.2c00407","article-title":"Immune-cell-derived exosomes for cancer therapy","volume":"19","author":"Zhao","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2026.118371_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113397","article-title":"Exosomes derived from primary cartilage stem\/progenitor cells promote the repair of osteoarthritic chondrocytes by modulating immune responses","volume":"143","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118371_b0685","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3390\/pharmaceutics13091493","article-title":"M1 macrophage-derived exosomes loaded with gemcitabine and deferasirox against chemoresistant pancreatic cancer","volume":"13","author":"Zhao","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.bcp.2026.118371_b0690","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1365928","article-title":"Exosomes derived from HUVECs alleviate ischemia-reperfusion induced inflammation in neural cells by upregulating KLF14 expression","volume":"15","author":"Qin","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0695","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/0929867327666200130103206","article-title":"The emerging roles of exosomes in the chemoresistance of hepatocellular carcinoma","volume":"28","author":"Zhang","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2026.118371_b0700","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70941","article-title":"Role of exosome in solid cancer progression and its potential therapeutics in cancer treatment","volume":"14","author":"Aakel","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.bcp.2026.118371_b0705","doi-asserted-by":"crossref","unstructured":"W-x Chen, Cai Y-q, Lv M-m, Chen L, Zhong S-l, Ma T-f, et al. Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs. Tumor Biol., 2014;35(10):9649-59.","DOI":"10.1007\/s13277-014-2242-0"},{"issue":"4","key":"10.1016\/j.bcp.2026.118371_b0710","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.4081\/ejh.2022.3529","article-title":"Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel via targeting miR-200b-3p\/Bcl-2 axis","volume":"66","author":"Li","year":"2022","journal-title":"Eur. J. Histochem.: EJH."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0715","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13058-023-01672-x","article-title":"Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217\/G3BP2 signaling pathway","volume":"25","author":"Xia","year":"2023","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0720","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41598-018-19339-5","article-title":"Exosome-mediated breast cancer chemoresistance via miR-155 transfer","volume":"8","author":"Santos","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118371_b0725","article-title":"Medicinal plants and human health: a comprehensive review of bioactive compounds, therapeutic effects, and applications","volume":"1\u201344","author":"Latif","year":"2025","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.bcp.2026.118371_b0730","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1491777","article-title":"Medicinal plants: bioactive compounds, biological activities, combating multidrug-resistant microorganisms, and human health benefits-a comprehensive review","volume":"16","author":"El-Saadony","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118371_b0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155629","article-title":"Rhizoma Alismatis Decoction improved mitochondrial dysfunction to alleviate SASP by enhancing autophagy flux and apoptosis in hyperlipidemia acute pancreatitis","volume":"129","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.118371_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155321","article-title":"Dehydroevodiamine ameliorates neurological dysfunction after traumatic brain injury in mice via regulating the SIRT1\/FOXO3a\/Bim pathway","volume":"125","author":"Xu","year":"2024","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.bcp.2026.118371_b0745","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.apsb.2023.11.001","article-title":"Development of Chinese herbal medicine for sensorineural hearing loss","volume":"14","author":"Wu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.bcp.2026.118371_b0750","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2174\/1570159X21666230717144752","article-title":"Neuroprotective strategies for stroke by natural products: advances and perspectives","volume":"21","author":"Liu","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bcp.2026.118371_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154732","article-title":"Active post-transcriptional regulation and ACLY-mediated acetyl-CoA synthesis as a pivotal target of Shuang-Huang-Sheng-Bai formula for lung adenocarcinoma treatment","volume":"113","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0760","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.bcp.2026.118371_b0765","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/biology15020191","article-title":"Medicinal plants for overcoming drug resistance in cervical cancer","volume":"15","author":"Marema","year":"2026","journal-title":"Biology"},{"issue":"8","key":"10.1016\/j.bcp.2026.118371_b0770","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/biomedicines10081948","article-title":"Plant-derived bioactive compounds in colorectal cancer: Insights from combined regimens with conventional chemotherapy to overcome drug-resistance","volume":"10","author":"Gavrilas","year":"2022","journal-title":"Biomedicines."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0775","article-title":"Cytotoxicity and modes of action of the methanol extracts of six cameroonian medicinal plants against multidrug\u2010resistant tumor cells","volume":"2013","author":"Kuete","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"6","key":"10.1016\/j.bcp.2026.118371_b0780","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/ptr.8481","article-title":"The role of medicinal plants in modulating epigenetic mechanisms: implications for cancer prevention and therapy","volume":"39","author":"Bendrihem","year":"2025","journal-title":"Phytother. Res."},{"issue":"11","key":"10.1016\/j.bcp.2026.118371_b0785","doi-asserted-by":"crossref","first-page":"20614","DOI":"10.3390\/molecules201119721","article-title":"Ursolic acid\u2014a pentacyclic triterpenoid with a wide spectrum of pharmacological activities","volume":"20","author":"Wo\u017aniak","year":"2015","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0790","doi-asserted-by":"crossref","first-page":"30782","DOI":"10.1038\/srep30782","article-title":"Folate-chitosan nanoparticles loaded with ursolic acid confer anti-breast cancer activities in vitro and in vivo","volume":"6","author":"Jin","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0795","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/419343","article-title":"Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo","volume":"2011","author":"Wang","year":"2011","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2026.118371_b0800","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fonc.2019.00501","article-title":"Ursolic acid reverses the chemoresistance of breast cancer cells to paclitaxel by targeting MiRNA-149-5p\/MyD88","volume":"9","author":"Xiang","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0805","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13148-019-0700-7","article-title":"Peptides as epigenetic modulators: therapeutic implications","volume":"11","author":"Janssens","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0810","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180411","article-title":"The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1","volume":"38","author":"Wu","year":"2018","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0815","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjc.2014.1","article-title":"Antitumour activity of the recombination polypeptide GST-NT21MP is mediated by inhibition of CXCR4 pathway in breast cancer","volume":"110","author":"Yang","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0820","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3892\/ijo.2017.4076","article-title":"N-peptide of vMIP-\u2161 reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer","volume":"51","author":"Wang","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0825","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s13346-020-00779-4","article-title":"Simultaneous delivery of anti-miRNA and docetaxel with supramolecular self-assembled \u201cchitosome\u201d for improving chemosensitivity of triple negative breast cancer cells","volume":"11","author":"Sun","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0830","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1038\/s41598-019-51581-3","article-title":"Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel","volume":"9","author":"Pasculli","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0835","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10549-017-4132-9","article-title":"MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer","volume":"162","author":"Raychaudhuri","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.bcp.2026.118371_b0840","doi-asserted-by":"crossref","first-page":"596","DOI":"10.20517\/cdr.2023.19","article-title":"Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7","volume":"6","author":"Apollonova","year":"2023","journal-title":"Cancer Drug Resist."},{"issue":"5","key":"10.1016\/j.bcp.2026.118371_b0845","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/gtmb.2022.0086","article-title":"Preanalytic and analytic quality system considerations in noncoding RNA biomarker development for clinical diagnostics","volume":"27","author":"Schleif","year":"2023","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0850","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12291-019-0811-0","article-title":"Single cell omics of breast cancer: an update on characterization and diagnosis","volume":"34","author":"Dwivedi","year":"2019","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.bcp.2026.118371_b0855","article-title":"CRISPR tools for physiology and cell state changes: potential of transcriptional engineering and epigenome editing","author":"Breunig","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2026.118371_b0860","doi-asserted-by":"crossref","unstructured":"P.W. Nagle, Plukker JTM, Muijs CT, van Luijk P, Coppes RP, editors. Patient-derived tumor organoids for prediction of cancer treatment response. Seminars in cancer biology; 2018: Elsevier.","DOI":"10.1016\/j.semcancer.2018.06.005"},{"key":"10.1016\/j.bcp.2026.118371_b0865","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cobme.2020.03.005","article-title":"Bioengineered tumor organoids","volume":"13","author":"Dominijanni","year":"2020","journal-title":"Curr. Opin. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.bcp.2026.118371_b0870","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.09.042","article-title":"In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection","volume":"148","author":"Bartfeld","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:09:55Z","timestamp":1788541795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226007100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":174,"alternative-id":["S0006295226007100"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118371","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The regulatory role of non-coding RNAs in taxane resistance of breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118371"}}